Site icon Market Stats News

Gene Synthesis Market Size to Surpass US$ 10.58 billion by 2030

The gene synthesis market size is predicted to hit around US$ 10.58 billion by 2030 and is expected to grow at a compound annual growth rate (CAGR) of 19.1% from 2021 to 2030.

Gene Synthesis Market (By Method: Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis; By Service: Antibody DNA Synthesis, Viral DNA Synthesis; By Application: Gene & Cell Therapy Development, Vaccine Development, Disease Diagnosis; By End-use: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Contract Research Organizations) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/39078

Gene synthesis space is offering enormous potential for new biological functionality. This has resulted in the introduction of supportive government policies associated with synthetic biology, thereby driving the market.

Industry participants strive for developing proprietary and new technologies to strengthen their market presence. Furthermore, the establishment of organizations and forums helps encourage researchers to opt and study genetic engineering-related concepts and develop innovative technologies, which is also a notable growth driver of this space.

Considering this space as a lucrative source of revenue, companies are focusing on collaborations with various universities for on-site training, online workshops, and sponsored projects to boost their expertise portfolio. This is also expected to generate interest among research professionals by helping them realize the potential of this field and therefore spurring adoption in the market.

Report Coverage

Report Scope Details
Market Size US$ 10.58 billion by 2030
Growth Rate CAGR of 19.1% From 2021 to 2030
Largest Market North America
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Method, Service, Application, End use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned GenScript; GENEWIZ; Boster Biological Technology; Twist Bioscience; ProteoGenix; Biomatik; ProMab Biotechnologies, Inc.; Thermo Fisher Scientific, Inc.; Integrated DNA Technologies, Inc.; OriGene Technologies, Inc.

COVID-19 has compressed the global economy and with it the manufacturing and marketing sector, production, disruption, financial.

The significant drop in COVID-19 cases due to mass inoculations programs worldwide are anticipated to increase revenue flow in the global economy and contribute to the growth of the car electrical products market. The COVID-19 impact has changed the growth projections of many sectors and businesses. The analysts put their excellent and well-researched opinions in the report. The opinions will help the stakeholders to make their strategy accordingly.

Key Players

Market Segmentation

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/39078

The study objectives of this report are:

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Application Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Gene Synthesis Market, By Method

7.1.  Gene Synthesis Market, by Method, 2021-2030

7.1.1.    Solid-phase Synthesis

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Chip-based Synthesis

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    PCR-based Enzyme Synthesis

7.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Gene Synthesis Market, By Service

8.1.  Gene Synthesis Market, by Service, 2021-2030

8.1.1.    Antibody DNA Synthesis

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Viral DNA Synthesis

8.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Gene Synthesis Market, By Application

9.1.  Gene Synthesis Market, by Application, 2021-2030

9.1.1.    Gene & Cell Therapy Development

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Vaccine Development

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Disease Diagnosis

9.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Gene Synthesis Market, By End-use

10.1.        Gene Synthesis Market, by End-use, 2021-2030

10.1.1.  Biotechnology & Pharmaceutical Companies

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Academic & Government Research Institutes

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Contract Research Organizations

10.1.3.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global Gene Synthesis Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Method (2017-2030)

11.1.2.  Market Revenue and Forecast, by Service (2017-2030)

11.1.3.  Market Revenue and Forecast, by Application (2017-2030)

11.1.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Method (2017-2030)

11.1.5.2.      Market Revenue and Forecast, by Service (2017-2030)

11.1.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.1.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Method (2017-2030)

11.1.6.2.      Market Revenue and Forecast, by Service (2017-2030)

11.1.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.1.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Method (2017-2030)

11.2.2.  Market Revenue and Forecast, by Service (2017-2030)

11.2.3.  Market Revenue and Forecast, by Application (2017-2030)

11.2.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Method (2017-2030)

11.2.5.2.      Market Revenue and Forecast, by Service (2017-2030)

11.2.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Method (2017-2030)

11.2.6.2.      Market Revenue and Forecast, by Service (2017-2030)

11.2.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Method (2017-2030)

11.2.7.2.      Market Revenue and Forecast, by Service (2017-2030)

11.2.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Method (2017-2030)

11.2.8.2.      Market Revenue and Forecast, by Service (2017-2030)

11.2.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Method (2017-2030)

11.3.2.  Market Revenue and Forecast, by Service (2017-2030)

11.3.3.  Market Revenue and Forecast, by Application (2017-2030)

11.3.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Method (2017-2030)

11.3.5.2.      Market Revenue and Forecast, by Service (2017-2030)

11.3.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Method (2017-2030)

11.3.6.2.      Market Revenue and Forecast, by Service (2017-2030)

11.3.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Method (2017-2030)

11.3.7.2.      Market Revenue and Forecast, by Service (2017-2030)

11.3.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Method (2017-2030)

11.3.8.2.      Market Revenue and Forecast, by Service (2017-2030)

11.3.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Method (2017-2030)

11.4.2.  Market Revenue and Forecast, by Service (2017-2030)

11.4.3.  Market Revenue and Forecast, by Application (2017-2030)

11.4.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Method (2017-2030)

11.4.5.2.      Market Revenue and Forecast, by Service (2017-2030)

11.4.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Method (2017-2030)

11.4.6.2.      Market Revenue and Forecast, by Service (2017-2030)

11.4.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Method (2017-2030)

11.4.7.2.      Market Revenue and Forecast, by Service (2017-2030)

11.4.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.7.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Method (2017-2030)

11.4.8.2.      Market Revenue and Forecast, by Service (2017-2030)

11.4.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.8.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Method (2017-2030)

11.5.2.  Market Revenue and Forecast, by Service (2017-2030)

11.5.3.  Market Revenue and Forecast, by Application (2017-2030)

11.5.4.  Market Revenue and Forecast, by End-use (2017-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Method (2017-2030)

11.5.5.2.      Market Revenue and Forecast, by Service (2017-2030)

11.5.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.5.5.4.      Market Revenue and Forecast, by End-use (2017-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Method (2017-2030)

11.5.6.2.      Market Revenue and Forecast, by Service (2017-2030)

11.5.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.5.6.4.      Market Revenue and Forecast, by End-use (2017-2030)

Chapter 12.  Company Profiles

12.1.              GenScript

12.1.1.  Company Overview

12.1.2.  Method Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Brooks Automation, Inc. (GENEWIZ)

12.2.1.  Company Overview

12.2.2.  Method Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Boster Biological Technology

12.3.1.  Company Overview

12.3.2.  Method Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Twist Bioscience

12.4.1.  Company Overview

12.4.2.  Method Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              ProteoGenix

12.5.1.  Company Overview

12.5.2.  Method Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Biomatik

12.6.1.  Company Overview

12.6.2.  Method Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              ProMab Biotechnologies, Inc.

12.7.1.  Company Overview

12.7.2.  Method Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Thermo Fisher Scientific, Inc.

12.8.1.  Company Overview

12.8.2.  Method Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Integrated DNA Technologies, Inc

12.9.1.  Company Overview

12.9.2.  Method Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           OriGene Technologies, Inc.

12.10.1.               Company Overview

12.10.2.               Method Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/39078

About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.

Contact Us:

call: +1 9197 992 333

Vision Research Report

Any Assistance, Email – sales@visionresearchreports.com

Exit mobile version